LegalizeVyhláška, kterou se mění vyhláška č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
| 365.2 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1 | ML | 5,60 | P |
|---|---|---|---|---|---|---|---|
| 365.3 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1 | ML | 3,90 | P |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | |||
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | |||
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,43 | O |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | |||
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | |||
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 48,84 | O |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S | |||
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O |
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 9,86 | O |
| 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O |
| 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O |
| 366.15 | N01BB10 | ropivacain | parent. | 1 | ML | 14,00 | O |
| 46610 | NAROPIN 2MG/ML | inf 5x100ml/200mg | APN | S | |||
| 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | S | |||
| 366.16 | N01BB09 | levobupivacain | parent. | 1 | ML | 14,00 | O |
| 03761 | CHIROCAINE 5 MG | inj cnc sol 10x10ml | ABB | I | |||
| 03755 | CHIROCAINE 2.5 MG | inj cnc sol 10x10ml | ABB | I | |||
| 367 | N01BX | ostatní lokální anestetika | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | |||
| 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | |||
| 94309 | MST CONTINUS | tbl ret 60x10mg | NPP | GB | |||
| 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F | |||
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | |
| 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | |||
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | |||
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | |||
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | |||
| 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | |||
| 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F | |||
| 368.3 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F | |||
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | |||
| 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | |||
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | |||
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | |||
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | |||
| 368.4 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | |||
| 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | |||
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | |||
| 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | |||
| 80409 | VENDAL RETARD | tbl fc 30x200mg | LAR | D | |||
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
| 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | |
| 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | |
| 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | |
| 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | |
| 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 54,20 | |
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 52,20 | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 32,71 | |
| 80452 | DHC CONTINUS 90MG | tbl ret 56x90mg | NPP | GB | |||
| 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB | |||
| 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | |||
| 80451 | DHC CONTINUS 60MG | tbl ret 56x60mg | NPP | GB | |||
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 27,86 | |
| 56875 | DHC CONTINUS 120MG | tbl ret 20x120mg | NPP | GB | |||
| 80453 | DHC CONTINUS 120MG | tbl ret 56x120mg | NPP | GB | |||
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,45 | O |
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | |||
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,33 | O |
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | |||
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | |
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 241,46 | P |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,24 | P |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |
Fentanyl s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
| 371 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | parent. | ||||
|---|---|---|---|---|---|---|---|
| 371.1 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.4 | GM | 55,68 | O |
| 02715 | DOLSIN | inj 10x1ml 5% | HBS | SK | |||
| 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 34,44 | O |
| 02716 | DOLSIN | inj 10x2ml 5% | HBS | SK | |||
| 371.3 | N02AC03 | piritramid | parent. | 300 | MG | 94,43 | O |
| 372 | N02AC | analgetika ze skupupiny difenylpropylaminových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 372.1 | N02AC05 | benzitramid | p.o. | 10 | MG | 12,71 | |
| 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 25,90 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SK | |||
| 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 101,10 | O |
| 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO | |||
| 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 375.1 | N02AE01 | buprenorfin | subling. | 1.2 | MG | 80,00 | |
| 375.2 | N02AE01 | buprenorfin (s řízeným uvolňováním 35 mikrogramu za hodinu) | transd. | 1 | DF | 254,00 | P |
| 375.3 | N02AE01 | buprenorfin (s řízeným uvolňováním 50,5 mikrogramu za hodinu) | transd. | 1 | DF | 370,00 | P |
| 375.4 | N02AE01 | buprenorfin (s řízeným uvolňováním 70 mikrogramu za hodinu) | transd. | 1 | DF | 480,00 | P |
Buprenorfin s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
| 375.5 | N02AX01 | tilidin | p.o. | 0.2 | GM | 19,78 | | | 03558 | VALORON | gtt 10ml 10% | IVX | CZ | | | | | 375.6 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.3 | GM | 21,80 | | | 53716 | PROTRADON | cps 500x50mg | PMP | CZ | | | | | 54082 | TRAMADOL 50 HF | cps 20x50mg | HMF | YU | | | | | 84631 | TRAMADOL-K | cps 20x50mg | KRK | SLO | | | | | 84376 | PROTRADON | cps 20x50mg | PMP | CZ | | | | | 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | | | 83094 | TRAMAL | cps 20x50mg | LEX | CZ | | | | | 12475 | TRAMABENE 50 TOBOLKY | cps 30x50mg | MCK | D | | | | | 67569 | MABRON 50MG | cps 20x50mg | MOE | CY | | | | | 67568 | MABRON 50MG | cps 10x50mg | MOE | CY | | | | | 375.7 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 29,40 | | | 43712 | TRAMAL RETARD 100 | tbl obd 30x100mg | LEX | CZ | | | | | 59672 | TRALGIT SR 100 | por tbl ret30x100mg | SLO | SK | | | | | 59673 | TRALGIT SR 100 | por tbl ret50x100mg | SLO | SK | | | | | 59671 | TRALGIT SR 100 | por tbl ret10x100mg | SLO | SK | | | | | 81423 | TRAMADOL LANNACHER RET.100 | por tbl ret20x100mg | LAR | A | | | | | 43711 | TRAMAL RETARD 100 | tbl obd 10x100mg | LEX | CZ | | | | | 32197 | TRAMADOL-K RETARD | por tbl ret30x100mg | KRK | SLO | | | | | 12687 | TRAMAL RETARD 100 | tbl obd 30x100mg | GRU | D | | | | | 41022 | TRAMADOL LANNACHER RET.200 MG | por tbl ret50x200mg | LAR | A | | | | | 53368 | TRAMAL RETARD 200 | tbl ret 10x200mg | LEX | CZ | | | | | 53366 | TRAMAL RETARD 150 | tbl ret 10x150mg | LEX | CZ | | | | | 40912 | TRAMADOL LANNACHER RET.150 MG | por tbl ret20x150mg | LAR | A | | | | | 40939 | TRAMADOL LANNACHER RET.150 MG | por tbl ret50x150mg | LAR | A | | | | | 81424 | TRAMADOL LANNACHER RET.100 | por tbl ret50x100mg | LAR | A | | | | | 41000 | TRAMADOL LANNACHER RET.200 MG | por tbl ret20x200mg | LAR | A | | | | | 375.8 | N02AX02 | tramadol hydrochlorid ( tekuté lékové formy) | p.o. | 0.3 | GM | 29,30 | | | 83095 | TRAMAL | gtt 1x10ml/1gm | LEX | CZ | | | | | 59077 | TRAMADOL AL | gtt 1x50ml/5gm | SDB | D | | | | | 53555 | PROTRADON KAPKY | gtt 1x10ml/1gm | PMP | CZ | | | | | 59076 | TRAMADOL AL | gtt 1x20ml/2gm | SDB | D | | | | | 12473 | TRAMABENE KAPKY | gtt 1x100ml/10gm | MCK | D | | | | | 56036 | TRAMAL | gtt 1x96ml/9.6gm | LEX | CZ | | | | | 12472 | TRAMABENE KAPKY | gtt 1x30ml/3gm | MCK | D | | | | | 84630 | TRAMADOL-K | gtt 1x10ml/1gm | KRK | SLO | | | | | 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect, parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 200,40 | O | | | | | | | | | | | 376.2 | N02AF01 | butorfanol | parent. | 12 | MG | 83,10 | O | | | | | | | | | | | 376.3 | N02AF02 | nalbufin | parent. | 80 | MG | 69,21 | O | | | | | | | | | | | 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,37 | O | | | | | | | | | | | 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 52,00 | | | 83096 | TRAMAL | sup 5x100mg | LEX | CZ | | | | | 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 102,84 | O | | 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D | | | | | 84628 | TRAMADOL-K 50MG/1ML | inj 5x1ml/50mg | KRK | SLO | | | | | 83097 | TRAMAL 50 | inj 5x1 mlZ50mg | LEX | CZ | | | | | 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 53,76 | O | | 67560 | MABRON | inj 100x2ml/100mg | MOE | CY | | | | | 58994 | TRAMADOL AL | inj 20x2ml/100mg | SDB | D | | | | | 58993 | TRAMADOL AL | inj 10x2ml/100mg | SDB | D | | | | | 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5x2ml/100mg | LAR | A | | | | | 76389 | TRAMADOL AL | inj 5x2ml/100mg | SDB | D | | | | | 83098 | TRAMAL 100 | inj 5x2ml/100mg | LEX | CZ | | | | | 67558 | MABRON | inj 5x2ml/100mg | MOE | CY | | | | | 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D | | | | | 84629 | TRAMADOL-K 100MG/2ML | inj 5x2ml/100mg | KRK | SLO | | | | | 53678 | TRAMADOL-SLOVAKOFARMA 100MG/2ML | inj 5x2ml/100mg | SLO | SK | | | | | 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 6,45 | | | 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK | | | | | 70487 | APO-ASA 325MG | tbl obd 100x325mg | APT | CND | | | | | 377.2 | N02BA02 | aloxiprin | p.o. | 3 | GM | 6,45 | | | | | | | | | | | | 377.3 | N02BA03 | cholin salicylát | p.o. | 3 | GM | 8,65 | | | | | | | | | | | | 377.4 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5,72 | | | | | | | | | | | | 377.5 | N02BA | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,65 | | | | | | | | | | | | 377.6 | N02BA | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3 | GM | 6,45 | | | 378 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 378.1 | N02BA | lysin salicylát | parent. | 3 | GM | 41,79 | | | | | | | | | | | | 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 38,58 | | | 00527 | NATRIUM SALICYLICUM BIOTIKA | inj 10x10ml 10% | HBS | SK | | | | | 378.3 | N02BA | lysin acetylsalicylát | parent. | 3 | GM | 40,37 | | | 379 | N02BE | analgetika ze skupiny anilidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,67 | | | 97656 | PARALEN 125 | tbl 20x125mg | LEX | CZ | | | | | 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 4,94 | | | 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | | | | | 84749 | MEDIPYRIN 500 | tbl 10x500mg | SLO | SK | | | | | 03837 | PARALEN 500 | tbl 10x500mg | LEX | CZ | | | | | 379.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3 | GM | 8,65 | | | 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 90,96 | | | 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D | | | | | 86010 | BEN-U-RON 125MG | sup 10x125mg | BNC | D | | | | | 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 26,98 | | | 94982 | MEXALEN | sup 6x1000mg | MCK | D | | | | | 59869 | MEDIPYRIN 250 | sup 10x250mg | SLO | SK | | | | | 86015 | BEN-U-RON 1000MG | sup 10x1000mg | BNC | D | | | | | 86014 | BEN-U-RON 500MG | sup 10x500mg | BNC | D | | | | | 86013 | BEN-U-RON 500MG | \ sup 5x500mg | BNC | D | | | | | 381 | N02B | ostatní analgetika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 381.1 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 44,53 | O | | 07981 | NOVALGIN | inj 10x2ml/1000mg | HBS | SK | | | | | 381.2 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,48 | O | | 55824 | NOVALGIN | inj 5x5ml/2500mg | HBS | SK | | | | | 381.3 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1 | DF | 8,10 | O | | 00457 | EUNALGIT | inj 5x2ml | LEX | CZ | | | | | 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 41,84 | O | | 382 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 382.1 | N02CA01 | dihydroergotamin | p.o. | 4 | MG | 1,22 | | | | | | | | | | | | 382.2 | N02CA07 | lisurid | p.o. | 75 | RG | 0,73 | | | | | | | | | | | | 382.3 | N02CA52 | ergotamin, kombinace | p.o. | 4 | DF | 9,38 | | | 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 111,52 | | | 90795 | DIHYDERGOT | inj 5x1ml 1 mg/ml | SAN | CH | | | | | 383.2 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1 | MG | 50,00 | | | 384 | N02C | jiná antimigrenika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 384.1 | N02CC01 | sumatriptan (do 50 mg včetně v jedné tabletě) | p.o. | 50 | MG | 105,00 | | | | | | | | | | | | 384.2 | N02CC01 | sumatriptan (nad 50 mg v jedné tabletě) | p.o. | 50 | MG | 78,75 | | | | | | | | | | | | 384.3 | N02CC01 | sumatriptan | parent. | 1 | DF | 899,35 | X | | | | | | | | | | | 384.4 | N02CC01 | sumatriptan (nosní sprej) | inhal. | 1 | DF | 292,50 | P |
Léčbu indikuje neurolog k terapii těžkého migrenozního záchvatu s časným zvracením, nejvíce v počtu 2 balení (4 dávky) za měsíc.
| 384.5 | N02CC02 | naratriptan | p.o. | 2,5 | MG | 105,00 | |
|---|---|---|---|---|---|---|---|
| 384.6 | N02CC03 | zolmitriptan | p.o. | 2,5 | MG | 105,00 | |
| 384.7 | N02CC03 | zolmitriptan (nosní sprej) | inhal. | 1 | DF | 292,50 | P |
| 384.8 | N02CC04 | rizatriptan | p.o. | 10 | MG | 105,00 | |
| 384.9 | N02CC06 | eletriptan | p.o. | 40 | MG | 105,00 | |
| 384.10 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 5,87 | |
| 384.11 | N02CX06 | oxetoron | p.o. | 0.12 | GM | 5,87 | |
| 384.12 | N02CX | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1 | DF | 21,66 | |
| 384.13 | N02CX | pipethiaden | p.o. | 3 | DF | 2,54 | |
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejích derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 385.1 | N03AA | fenobarbital pseudonorefed. | p.o. 0.1 | GM | 2,05 | ||
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,08 | |
| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | |||
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,27 | |
| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | |||
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 GM | 4.72 | ||
| 01365 | MYSOLINE | tbl 100x250mg | ZNC | GB | |||
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 45,51 | |
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejích derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 126,25 | O |
| 66845 | GARDENAL | inj sic 1x40mg+solv | RPC | F | |||
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 13,46 | O |
| 84449 | LUMINAL | inj 5x1 ml/219mg | DET | D | |||
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,81 | |
| 62234 | EPILAN D GEROT | tbl 100x100mg | GER | A | |||
| 00297 | SODANTON | tbl 20x100mg | SLO | SK | |||
| 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,44 | |
| 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 2,40 | |
| 02625 | SANEPIL | tbl 20 (blistr) | SLO | SK | |||
| 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 116,04 | O |
| 59080 | EPANUTIN PARENTERAL | inj 5x5ml/250mg | GOD | D | |||
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,78 | |
| 92041 | PETINIMID | cps 100x250mg | GER | A | |||
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22,69 | |
| 11037 | SUXILEP | gtt 50gm 50% | PHW | D | |||
| 02110 | PETINIMID | sir 250ml 12.5gm | GER | A | |||
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | |||
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 24,78 | |
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 33,60 | |
| 59908 | RIVOTRIL 2.5MG/ML | gtt 1x10ml/25mg | ROX | I | |||
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 24,15 | |
| 03031 | RIVOTRIL | tbl 50x0.5mg | HLR | CH | |||
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 12,71 | |
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | ||||
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 230,32 | O |
| 03030 | RIVOTRIL | inj 5x1ml/1mg+solv. | HLR | CH | |||
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,16 | |
| 62309 | APO-CARBAMAZEPINE 200MG | tbl 100x200mg | APT | CND | |||
| 98080 | NEUROTOP | tbl 50x200mg | GER | A | |||
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 16,94 | |
| 71954 | TIMONIL RETARD | tbl 50x150mg | DET | D | |||
| 60164 | TIMONIL RETARD | tbl 50x300mg | DET | D | |||
| 60165 | TIMONIL RETARD | tbl 100x300mg | DET | D | |||
| 60166 | TIMONIL RETARD | tbl 50x600mg | DET | D | |||
| 96305 | NEUROTOP RETARD 300 | tbl 50x300mg | GER | A | |||
| 96306 | NEUROTOP RETARD 600 | tbl 50x600mg | GER | A | |||
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 42,52 | |
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,10 | |
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (natrium valproát) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 19,06 | |
| 08768 | CONVULEX | cps 100x150mg | GER | A | |||
| 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | |||
| 393.2 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 15,64 | |
| 61185 | ORFIRIL 600 | drg 50x600mg | DET | D | |||
| 75296 | CONVULEX | cps 100x500mg | GER | A | |||
| 93334 | EVERIDEN | tbl 100x300mg | SLO | SK | |||
| 08769 | CONVULEX | cps 100x300mg | i GER | A | |||
| 61184 | ORFIRIL 300 | drg 50x300mg | DET | D | |||
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.5 | GM | 26,88 | |
| 57712 | ORFIRIL LONG 300MG | cps ret 50x300mg | DET | D | |||
| 57713 | ORFIRIL LONG 300MG | cps ret 100x300mg | DET | D | |||
| 58785 | CONVULEX CR 300 MG | tbl ret 50x300mg | GER | A | |||
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 28,46 | |
| 58787 | CONVULEX CR 500 MG | tbl ret 50x500mg | GER | A | |||
| 57719 | ORFIRIL LONG 1000MG | tbl ret 100x1000mg | DET | D | |||
| 57718 | ORFIRIL LONG 1000MG | tbl ret 50x1000mg | DET | D | |||
| 57716 | ORFIRIL LONG 500MG | tbl ret 100x500mg | DET | D | |||
| 57715 | ORFIRIL LONG 500MG | tbl ret 50x500mg | DET | D | |||
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 31,90 | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 29,41 | |
| 44997 | DEPAKINE CHRONO 500MG SECABLE | tbl ret 100x500mg | SWI | F | |||
| 393.7 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.5 | GM | 25,63 | |
| 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | |||
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 25,61 | L/PSY,NEU |
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 135,36 | L/PSY,NEU |
| 80370 | SABRIL | portblflm 100x500mg | MDD | GB | |||
| 46408 | SABRIL | portblflm 100x500mg | PBH | F | |||
| 394.3 | N03AG06 | tiagabin | p.o. | 30 | MG | 135,36 | L/PSY,NEU |
| 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 395.1 | N03AG01 | natrium valproát | parent. | 1.5 | GM | 1201,85 | K |
| 54238 | ORFIRIL INJEKTIONSLOSUNG | inj 5x3ml/300mg | DET | D | |||
| 396 | N03AX | ostatní antiepileptika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,11 | L/PSY,NEU |
| 55852 | OSPOLOT | tbl obd 50x200mg | DET | D |
Lamotrigin, disperzní léková forma: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být léčeny tabletovou formou.
| 396.2 | N03AX09 | lamotrigin (disperzní forma do 2 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 500,00 | P |
|---|---|---|---|---|---|---|---|
| 396.3 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 300,00 | P |
| 42584 | LAMICTAL 5 MG | por tbl mnd 30x5mg | GOW | GB | |||
| 396.4 | N03AX09 | lamotrigin (disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 42585 | LAMICTAL 25 MG | por tbl mnd 30x25mg | GOW | GB | |||
| 396.5 | N03AX09 | lamotrigin (disperzní forma nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 144,00 | P |
| 42586 | LAMICTAL 100 MG | por tbl mnd30x100mg | GOW | GB | |||
| 396.6 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| 396.7 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 396.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| 42491 | LAMICTAL 100 MG | portblnob100x100mg | GOK | GB | |||
| 396.9 | N03AX10 | felbamat | p.o. | 2.4 | GM | 283,03 | L/PSY,NEU |
| 77005 | TALOXA 600MG | tbl 100x600mg | SCH | B | |||
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B | |||
| 77004 | TALOXA 400MG | tbl 100x400mg | SCH | B |
Topiramat - léková forma tobolky: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.
| 396.10 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 300,00 | P |
|---|---|---|---|---|---|---|---|
| 396.11 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 185,00 | P |
| 396.12 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| 44671 | TOPAMAX 25MG | tbl obd 28x25mg-bl. | CIL | CH | |||
| 396.13 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 44675 | TOPAMAX 50MG | tbl obd 28x50mg-bl. | CIL | CH | |||
| 396.14 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| 396.15 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 135,36 | L/PSY,NEU |
| 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | |||
| 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | |||
| 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | |||
| 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | |||
| 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | |||
| 396.16 | N03AX14 | levetiracetam | p.o. | 2 | GM | 135,36 | L/PSY,NEU |
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 7,15 | |
| 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | |||
| 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,22 | |
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | |
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | |
| 57783 | KEMADRIN | tbl 100x5mg | ACA | GB | |||
| 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | |||
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 398.1 | N04AA02 | biperiden | parent. | 10 MG | 58,52 | O | |
| 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | |||
| 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | |||
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O |
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,12 | |
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | |
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | |
| 45241 | ISICOM 100MG | tbl 100x125mg | DET | D | |||
| 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 03591 | NAKOM | tbl 100x275mg | LEK | SLO | |||
| 45244 | ISICOM 250MG | tbl 100x275mg | DET | D | |||
| 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 22,00 | |
| 31026 | MADOPAR 250 | por tblnob100x250mg | HLR | CH | |||
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| 12073 | MADOPAR HBS | cps 30x125mg | HLR | CH | |||
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,52 | L/NEU,PSY,GER |
| 02871 | VIREGYT-K | cps 50x100mg | EGI | H | |||
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY,GER |
| 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H |
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 402.1 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 5,49 | L/NEU,PSY,GER |
| 59279 | SELEGILIN-RATIOPHARM 5 MG | tbl 50x5mg | MCK | D | |||
| 03073 | APO-SELEG | por tbl nob100x5mg | APT | CND | |||
| 03074 | APO-SELEG | por tbl nob 50x5mg | APT | CND | |||
| 13017 | NIAR | tbl 30x5mg | KNO | D | |||
| 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,10 | L/NEU,PSY,GER |
| 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X |
| 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 176,94 | X |
| 402.5 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X |
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X |
| 402.7 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X |
| 64928 | ALMIRID | tbl 20x20mg | MON | I | |||
| 402.8 | N04BC04 | ropinirol do 2 mg v jedné tabletě včetně | p.o. | 6 | MG | 72,83 | X |
| 402.9 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6 | MG | 66,50 | X |
| 402.10 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X |
| 402.11 | N04BX02 | entacapon | p.o. | 1 | GM | 175,00 | X |
| 54466 | COMTAN | tbl obd 30x200mg | NPA | D | |||
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,19 | |
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,53 | |
| 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 62,76 | |
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,94 | |
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | |
| 404 | N05AA | neuroteptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O |
| 00560 | PLEGOMAZIN 0.5% | inj 10x5ml/25mg | EGI | H | |||
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O |
| 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | |||
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,83 | |
| 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | |||
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | |
| 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 6,99 | |
| 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,70 | |
| 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 3,77 | O |
| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | |||
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothlazinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,19 | L/NEU,PSY,GER |
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY,GER |
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 12,34 | |
| 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | |||
| 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | |||
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | |
| 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | |||
| 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,12 | |
| 58378 | APO-HALOPERIDOL 2MG/ML | gtt 1x100ml/200mg | APT | CND | |||
| 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,72 | |
| 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 3,91 | |
| 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 24,94 | |
| 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 9,82 | O |
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16,72 | O |
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,52 | O |
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,10 | O |
| 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 50,10 | O |
| 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,28 | |
| 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 15,70 | |
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | |
| 410.4 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 13,27 | |
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | |||
| 410.5 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 8,18 | |
| 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | |||
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,27 | |
| 57827 | CISORDINOL 25MG | tbl obd 50x25mg-pp | LUN | DK | |||
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,55 | O |
| 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 15,16 | O |
| 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,03 | O |
| 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 94,25 | O |
| 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK | |||
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O |
| 412 | N05AG | neuroleptika ze skupiny difenylbutytpiperidinových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,76 | |
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,01 | |
| 01637 | SEMAP | tbl 12x20mg | JAN | P | |||
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,39 | O |
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 414.1 | N05AH01 | loxapin | p.o. | 0,1 | GM | 52,20 | L/PSY |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 57,16 | L/PSY,NEU |
| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30x25mg | SBV | NL | |||
| 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 50,20 | L/PSY,NEU |
| 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 46,03 | L/PSY |
| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob30x100mg | SBV | NL | |||
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 131,70 | P |
Olanzapin, quetiapin v dávce nad 25 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
- b) rizika klinických důsledků zvýšené prolaktinemie (amenorea, gynekomastie, galaktorhea, osteoporóza, infertilita, impotence, poporodní psychické poruchy) nebo je-li ustanovena hyperprolaktinemie ≥ 1400mlU/l)
| 414.6 | N05AH04 | quetiapin do 25 mg včetně v jedné tabletě | p.o. | 0,4 | GM | 260,00 | P |
|---|---|---|---|---|---|---|---|
Quetiapin v dávce do 25 mg v jedné tabletě indikuje neurolog u pacientů s psychotickými komplikacemi dopaminergní léčby Parkinsonovy nemoci.
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 131,70 | P |
|---|---|---|---|---|---|---|---|
| 414.8 | N05AX11 | zotepin | p.o. | 0,2 | GM | 76,90 | L/PSY |
| 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H |
| 415.2 | N05AH03 | olanzapin | parent. | 10 | MG | 177,00 | H |
| 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 35,00 | |
| 54432 | PROSULPIN 50MG | tbl 30x50mg | PMP | CZ | |||
| 46751 | SULPIROL 50 | por cps dur100x50mg | SFS | D | |||
| 46750 | SULPIROL 50 | por cps dur 50x50mg | SFS | D | |||
| 46749 | SULPIROL 50 | por cps dur 20x50mg | SFS | D | |||
| 11468 | PROSULPIN 50MG | tbl 60x50mg | PMP | CZ | |||
| 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 20,83 | L/PSY,NEU |
| 46743 | SULPIROL 200 | por tblnob100x200mg | HEX | D | |||
| 11149 | PROSULPIN 200MG | tbl 60x200mg | PMP | CZ | |||
| 46748 | SULPIROL 200 | por tbl nob20x200mg | SFS | D | |||
| 46746 | SULPIROL 200 | por tblnob100x200mg | SFS | D | |||
| 46741 | SULPIROL 200 | por tbl nob20x200mg | HEX | D | |||
| 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | |||
| 46742 | SULPIROL 200 | por tbl nob50x200mg | HEX | D | |||
| 46747 | SULPIROL 200 | por tbl nob50x200mg | SFS | D | |||
| 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 27,00 | |
| 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 41,87 | |
| 416.5 | N05AL05 | amisulprid (pevné lékové formy)do 50 mg v jedné tabletě včetně | p.o. | 1 | DF | 16,70 | L/PSY.NEU |
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 131,70 | P |
Amisulprid v dávce nad 50 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
- b) rizika klinických důsledků zvýšené prolaktinemie (amenorea, gynekomastie, galaktorhea, osteoporóza, infertilita, impotence, poporodní psychické poruchy) nebo je-li ustanovena hyperprolaktinemie ≥ 1400mlU/l)
| 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | ||||
|---|---|---|---|---|---|---|---|
| 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 71,33 | O/PSY,NEU |
| 89922 | DOGMATIL 100 | inj 6x2ml/100mg | SSJ | F | |||
| 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 55,43 | O |
| 47628 | TIAPRIDAL | injsol 12x2ml/100mg | SBN | F | |||
| 418 | N05AN | lithium | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 418.1 | N05AN01 | lithium do 0,3 g včetně v jedné tabletě | p.o. | 1 | GM | 6,95 | |
| 02481 | LITHIUM CAERBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | |||
| 418.2 | N05AN01 | lithium nad 0,3 g v jedné tabletě | p.o. | 1 | GM | 4,67 | |
| 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | |||
| 419 | N05AX | ostatní antipsychotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 419.1 | N05AX08 | risperidon (s obsahem do 1 mg včetně) | p.o. | 5 | MG | 92,00 | L/PSY, NEU, GER, INT |
| 42525 | RISPEN 1 | por tbl flm 50x1mg | LEX | CZ | |||
| 419.2 | N05AX08 | risperidon (s obsahem nad 1 mg ) | p.o. | 5 | MG | 94,60 | L/PSY, NEU, GER, INT |
| 42529 | RISPEN 3 | por tbl flm 50x3mg | LEX | CZ | |||
| 42527 | RISPEN 2 | por tbl flm 50x2mg | LEX | CZ | |||
| 419.3 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5 | MG | 115,00 | L/PSY, NEU, GER, INT |
| 419.4 | N05AX08 | risperidon s obsahem do 25 mg v jedné ampuli včetně | parent. | 1.8 | MG | 303,26 | O/P |
| 419.5 | N05AX08 | risperidon s obsahem nad 25 mg v jedné ampuli | parent. | 1.8 | MG | 291,13 | O/P |
Risperidon ve formě depotní injekce je indikován psychiatrem u schizofrenních pacientů s dobrou prognózou po opakované hospitalizaci z důvodů nedodržování léčby za vzniku relapsu s agresivitou. Je indikován pouze u pacientů, kteří netolerují klasická antipsychotika nebo jsou tato u nich neúčinná. Léčba se ukončí pokud pacient relabuje během 12 měsíců terapie a to i přes optimalizaci dávky nebo u pacientů, kteří nespolupracují.
| 419.6 | N05AE03 | sertindol | p.o. | 1 | DF | 131,70 | P |
|---|---|---|---|---|---|---|---|
| 13039 | SERDOLECT 4MG | tbl obd 30x4mg | LUN | DK | |||
| 419.7 | N05AE04 | ziprasidon | p.o. | 80 | MG | 131,70 | P |
| 44645 | ZELDOX 80MG | cps 30x80mg | MAC | D |
Sertindol a ziprasidon indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
- b) rizika klinických důsledků zvýšené prolaktinemie (amenorea, gynekomastie, galaktorhea, osteoporóza, infertilita, impotence, poporodní psychické poruchy) nebo je-li ustanovena hyperprolaktinemie ≥ 1400mlU/l)
| 419.8 | N05AE04 | ziprasidon | parent. | 40 | MG | 177,00 | H | | 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 420.1 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0,68 | | | | | | | | | | | | 420.2 | N05BA01 | diazepam | p.o. | 10 | MG | 0,68 | | | 02478 | DIAZEPAM SLOVAKOFARMA | tbl 20x10mg | SLO | SK | | | | | 420.3 | N05BA02 | chlordiazepoxid | p.o. | 30 | MG | 0,68 | | | | | | | | | | | | 420.4 | N05BA03 | medazepam | p.o. | 20 | MG | 0,68 | | | | | | | | | | | | 420.5 | N05BA04 | oxazepam | p.o. | 50 | MG | 0,68 | | | | | | | | | | | | 420.6 | N05BA05 | klorazepát draselný | p.o. | 20 | MG | 0,68 | | | | | | | | | | | | 420.7 | N05BA06 | lorazepam | p.o. | 2.5 | MG | 0,68 | | | | | | | | | | | | 420.8 | N05BA08 | bromazepam | p.o. | 10 | MG | 0,68 | | | | | | | | | | | | 420.9 | N05BA09 | klobazam | p.o. | 20 | MG | 0,68 | | | | | | | | | | | | 420.10 | N05BA11 | prazepam | p.o. | 30 | MG | 0,68 | | | | | | | | | | | | 420.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1 | MG | 0,68 | | | | | | | | | | | | 420.12 | N05BA12 | alprazolam (1 mg a více v jedné tabletě) | p.o. | 1 | MG | 2,49 | P |
Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.
| 59758 | FRONTIN 1.0MG | tbl 30x1mg | EGI | H | | | | | 59759 | FRONTIN 1.0MG | tbl 100x1mg | EGI | H | | | | | | | | | | | | | | 421 | N05BA | anxiolytjka ze skupiny derivátů benzodiazepinu | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 108,16 | L/NEU,PSY,PDD | | 04326 | STESOLID 5MG | enm 5x2.5ml/5mg | ALO | N | | | | | 69417 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/5mg | DET | D | | | | | 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 67,14 | L/NEU,PSY,PDD | | 04327 | STESOLID 10MG | enm 5x2.5ml/10mg | ALO | N | | | | | 69418 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/10mg | DET | D | | | | | 422 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 422.1 | N05BA01 | diazepam | parent. | 10 | MG | 7,53 | | | 96610 | APAURIN | inj 10x2ml/10mg | KRK | SLO | | | | | 422.2 | N05BA05 | klorazepát draselný | parent. | 20 | MG | 14,66 | | | 423 | N05BX | ostatní anxiolytika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 423.1 | N05BB01 | hydroxyzin | p.o. | 75 | MG | 0,68 | | | | | | | | | | | | 423.2 | N05BC01 | meprobamat | p.o. | 1.2 | GM | 0,68 | | | | | | | | | | | | 423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 16,38 | | | 85656 | DORSIFLEX | tbl 30x200mg | LEK | SLO | | | | | 423.4 | N05BE01 | buspiron | p.o. | 30 | MG | 2,49 | | | 424 | N05CA | hypnotika ze skupiny barbiturátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 424.1 | N05CA01 | pentobarbital | parent. | 0.1 | GM | 23,32 | H | | | | | | | | | | | 424.2 | N05CM | dexmedetomidin | parent. | 500 | RG | 1300,00 | H | | 425 | N05CD | hypnotika ze skupiny benzodiazepinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,61 | O | | 90559 | ROHYPNOL INJ | inj 5x1ml+5x1ml sol | LEX | CZ | | | | | 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 105,75 | O | | 58163 | FULSED | inj sol10x1ml/5mg | RXY | IND | | | | | 53631 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | ANN | IRL | | | | | 53633 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | ANN | IRL | | | | | 02922 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | SOO | NL | | | | | 00903 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | SOO | NL | | | | | 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 72,90 | O | | 02924 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | SOO | NL | | | | | 53635 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | ANN | IRL | | | | | 426 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 426.1 | N06AA01 | desipramin | p.o. | 0.1 | GM | 17,11 | | | | | | | | | | | | 426.2 | N06AA02 | imipramin | p.o. | 0.1 | GM | 9,90 | | | | | | | | | | | | 426.3 | N06AA04 | klomipramin | p.o. | 0.1 | GM | 14,49 | | | 08557 | ANAFRANIL | drg 30x25mg | CGC | CH | | | | | 93828 | ANAFRANIL SR GEIGY 75 | tbl obd 20x75mg | CGC | CH | | | | | 426.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12,02 | | | | | | | | | | | | 426.5 | N06AA07 | lofepramin | p.o. | 105 | MG | 14,66 | | | | | | | | | | | | 426.6 | N06AA08 | dibenzepin | p.o. | 0.3 | GM | 15,24 | | | 02641 | NOVERIL 240 | tbl 20x240mg | WAN | CH | | | | | 426.7 | N06AA09 | amitriptylin | p.o. | 75 | MG | 2,85 | | | 87167 | AMITRIPTYLIN SLOVAKOFARMA | tbl obd 50x28.3mg | SLO | SK | | | | | 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 9,10 | | | | | | | | | | | | 426.9 | N06AA16 | dosulepin | p.o. | 150 | MG | 9,78 | | | 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | | | | | 77047 | PROTHIADEN 75 | tbl obd 30x75mg | LEX | CZ | | | | | 426.10 | N06AA21 | maprotilin | p.o. | 100 | MG | 12,28 | | | 45757 | MAPROTIBENE 25MG | tbl obd 20x25mg | MCK | D | | | | | 45759 | MAPROTIBENE 50MG | tbl obd 20x50mg | MCK | D | | | | | 427 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 427.1 | N06AA01 | desipramin | parent. | 0.1 | GM | 96,44 | O | | | | | | | | | | | 427.2 | N06AA02 | imipramin | parent. | 0.1 | GM | 48,39 | O | | | | | | | | | | | 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 95,76 | O | | 02884 | ANAFRANIL | inj 10x2ml 25mg | CGC | CH | | | | | 427.4 | N06AA08 | dibenzepin | parent. | 0.3 | GM | 96,44 | O | | | | | | | | | | | 427.5 | N06AA09 | amitriptylin | parent. | 75 | MG | 30,79 | O | | | | | | | | | | | 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 108,64 | O | | 94560 | LUDIOMIL | inj 10x5ml/25mg | CGC | CH | | | | | 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 14,00 | | | 54073 | FLOXET 20MG | cps 14x20mg | EGI | H | | | | | 54422 | MAGRILAN | cps 10x20mg | MOE | CY | | | | | 54423 | MAGRILAN | cps 30x20mg | MOE | CY | | | | | 64657 | FLUOXIN | por cps dur 50x20mg | SFS | D | | | | | 56471 | FLUVAL | cps 14x20mg | KRK | SLO | | | | | 56472 | FLUVAL | cps 28x20mg | KRK | SLO | | | | | 54074 | FLOXET 20MG | cps 28x20mg | EGI | H | | | | | 13022 | PORTAL | cps 14x20mg | LEK | SLO | | | | | 98791 | DEPREX LÉČIVA | por cps dur 30x20mg | LEX | CZ | | | | | 98779 | FLUOXIN | por cps dur 30x20mg | SFS | D | | | | | 95458 | FLUOXETIN-RATIOPHARM 20 MG | por cpsdur100x20mg | MCK | D | | | | | 95457 | FLUOXETIN-RATIOPHARM 20 MG | por cps dur30x20mg | MCK | D | | | | | 92346 | DEPREX | cps 30x20mg | LEX | CZ | | | | | 13023 | PORTAL | cps 28x20mg | LEK | SLO | | | | | 64658 | FLUOXIN | por cps dur100x20mg | SFS | D | | | | | 64656 | FLUOXIN | por cps dur 20x20mg | SFS | D | | | | | 44397 | APO-FLUOXETINE | cps 30x20mg | APT | CND | | | | | 44398 | APO-FLUOXETINE | cps 100x20mg | APT | CND | | | | | 59274 | FLUMIREX | cps 30x20mg | CHN | H | | | | | 428.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20 | MG | 18,00 | L/PSY,SEX,NEU, INT,GER | | 03976 | CITALEC 10 | tbl obd30x10mg-bli | LEX | CZ | | | | | 428.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | 03978 | CITALEC 20 | tbl obd30x20mg | LEX | CZ | | | | | 30956 | CITALEC 40 | tbl obd30x40mg(bli) | LEX | CZ | | | | | 428.4 | N06AB04 | citalopram, tekuté lékové formy | p.o. | 20 | MG | 18,00 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 428.5 | N06AB05 | paroxetin | p.o. | 20 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | 41158 | PAROLEX 20 | por tbl flm 60x20mg | AAZ | DK | | | | | 41239 | PAROLEX 20 | por tbl flm 60x20mg | AAZ | DK | | | | | 41242 | PAROLEX 40 | por tbl flm 20x40mg | AAZ | DK | | | | | 41243 | PAROLEX 40 | por tbl flm 60x40mg | AAZ | DK | | | | | 41244 | PAROLEX 40 | por tbl flm 100x40mg | AAZ | DK | | | | | 41245 | PAROLEX 40 | por tbl flm 20x40mg | AAZ | DK | | | | | 41253 | PAROLEX 40 | por tbl flm 60x40mg | AAZ | DK | | | | | 41262 | PAROLEX 40 | por tbl flm 100x40mg | AAZ | DK | | | | | 96217 | PAROLEX 40 | por tbl flm 30x40mg | AAZ | DK | | | | | 96216 | PAROLEX 40 | por tbl flm 30x40mg | AAZ | DK | | | | | 96215 | PAROLEX 20 | por tbl flm 30x20mg | AAZ | DK | | | | | 96214 | PAROLEX 20 | por tbl flm 30x20mg | AAZ | DK | | | | | 428.6 | N06AB06 | sertralin | p.o. | 50 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | 59556 | SERLIFT 50 MG | por tblflm 30x50mg | RXY | IND | | | | | 47325 | SERTRALIN IREX 100 MG | por tblflm 28x100mg | OMA | IS | | | | | 59560 | SERLIFT 100 MG | por tbl flm30x100mg | RXY | IND | | | | | 32743 | SERTRALIN IREX 50 MG | por tbl flm 28x50mg | OMA | IS | | | | | 428.7 | N06AB08 | fluvoxamin (do 50 mg v jedné tabletě včetně) | p.o. | 100 | MG | 18,00 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 428.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 428.9 | N06AB10 | escitalopram | p.o. | 10 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | 429 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 228,29 | O/PSY,SEX | | 60113 | SEROPRAM | inf 10x1ml/40mg | LUN | DK | | | | | 430 | N06A | ostatní antidepresiva | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,30 | L7PSY,SEX,NEU, | | | | | | | | | | | 430.2 | N06AF04 | tranylcypromin | p.o. | 10 | MG | 5.03 | L/PSY,SEX,NEU | | | | | | | | | | | 430.3 | N06AG02 | moklobemid do 150mg v jedné tabletě včetně | p.o. | 0.3 | GM | 18,00 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 430.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.3 | GM | 16,70 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 430.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60 | MG | 16,70 | L/PSY,SEX,NEU | | | | | | | | | | | 430.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60 | MG | 17,35 | L7PSY.SEX.NEU | | 45771 | MIABENE 30MG | tbl obd 20x30mg | MCK | D | | | | | 430.7 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,22 | L/PSY,SEX,NEU | | | | | | | | | | | 430.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.3 | GM | 17,60 | L/PSY,SEX,NEU | | | | | | | | | | | 430.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400 | MG | 20,70 | L/PSY,SEX,NEU | | | | | | | | | | | 430.10 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,22 | L/PSY,SEX,NEU | | | | | | | | | | | 430.11 | N06AX11 | mirtazapin | p.o. | 30 | MG | 22,25 | L/PSY,SEX,NEU | | | | | | | | | | | 430.12 | N06AX12 | bupropion | p.o. | 200 | MG | 18,00 | L/PSY,SEX,NEU | | | | | | | | | | | 430.13 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER | | | | | | | | | | | 430.14 | N06AX16 | venlafaxin | p.o. | 100 | MG | 22,25 | L/NEU,PSY,SEX | | | | | | | | | | | 430.15 | N06AX17 | milnacipran | p.o. | 100 | MG | 22,25 | L/NEU,PSY,SEX | | | | | | | | | | | 430.16 | N06AX18 | reboxetin | p.o. | 8 | MG | 22,25 | L/NEU,PSY,SEX | | | | | | | | | | | 430.17 | V11 | hyperici extractum siccum normatum (LI 160) | p.o. | 900 | MG | 10,80 | | | 431 | N06BA | centrálně působící stimulancia | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,00 | L/NEU,PSY,PDD, SEX | | 83328 | RITALIN | tbl 30x10mg | CGC | CH | | | | | 431.2 | N06BA07 | modafinil | p.o. | 300 | MG | 9,00 | L/NEU,PSY,PDD, SEX | | 432 | N06BX | ostatní psychostimulancia a nootropika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Pyritinol, piracetam a vinpocetin indikuje neurolog a psychiatr pacientům s nejméně jedou z následujících diagnóz:
1) afasie cévního původu a poruchy kognitivních funkcí po prodělané CPM,
2) stav po kraniocerebrálních traumatech - poúrazové kognitivní a psychické dysfunkce,
3) vaskulární demence,
4) kortikální myoklonus,
5) DMO.
Dále je psychiatrem, neurologem a othorynolaryngologem vinpocetin indikován pacientům s vertigem a tinitem.
Tekuté lékové formy jsou indikovány pacientům ve výše uvedených indikacích, postižených současně poruchou polykání.
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 6,50 | P |
|---|---|---|---|---|---|---|---|
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 18,12 | P |
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 5,85 | P |
| 81598 | PIRABENE 800MG | tbl obd 100x800mg | MCK | D | |||
| 64864 | PIRACETAM AL 1200 | por tblflm30x1200mg | APA | D | |||
| 64865 | PIRACETAM AL 1200 | por tblflm60x1200mg | APA | D | |||
| 66646 | PIRACETAM AL 800 | tbl obd 30x800mg | APA | D | |||
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | |||
| 81600 | PIRABENE 1200MG | tbl obd 60x1200mg | MCK | D | |||
| 10032 | PIRACETAM AL 800 | tbl obd 60x800mg | APA | D | |||
| 66647 | PIRACETAM AL 800 | tbl obd 50x800mg | APA | D | |||
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 18,12 | P |
| 88156 | NOOTROPIL 20% ORAL | sol 1x125ml 20% | UCB | B | |||
| 04289 | NOOTROPIL 33% ORAL | sol 1x125ml 33% | UCB | B | |||
| 432.5 | N06BX18 | vinpocetin | p.o. | 15 | MG | 6,50 | P |
Léčbu inhibitory acetylcholinesterázy (IAchE) ordinuje neurolog nebo psychiatr pacientům, u kterých je diagnosticky vyloučena demence jiného typu než Alzheimerova a potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 20 – 13 bodů včetně.
Po 12.týdnech (3 měsíce) od zahájení podávání IAchE je provedeno další vyšetření pacienta škálou MMSE. Léčba IAchE je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby IAchE). Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby. Léčba IAchE není hrazena u pacientů, u nichž po 6/9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.
Léčbu memantinem indikuje neurolog nebo psychiatr pacientům, u kterých je potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 6 – 17 bodů včetně. Léčba memantinem není hrazena u pacientů, u nichž poklesne zjištěné skóre škály MMSE pod 6 bodů.
| 432.6 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1 | DF | 58,00 | P |
|---|---|---|---|---|---|---|---|
| 432.7 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1 | DF | 113,00 | P |
| 432.8 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2 | DF | 58,00 | P |
| 432.9 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2 | DF | 113,00 | P |
| 432.10 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2 | DF | 58,00 | P |
| 432.11 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2 | DF | 113,00 | P |
| 432.12 | N06DX01 | memantin | p.o. | 20 | MG | 85,00 | P |
| 432.13 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120 | MG | 8,10 | L/PSY, NEU, INT, OPH, ORL,GER |
| 58478 | GINGIUM ROZTOK | por gttsol2x100ml | SFS | D | |||
| 58477 | GINGIUM ROZTOK | por gttsol1x100ml | SFS | D | |||
| 58791 | GINGIUM TABLETY | por tbl flm100x40mg | SFS | D | |||
| 42483 | GINGIUM TABLETY | por tbl flm120x40mg | SFS | D | |||
| 433 | N06BX | ostatní psychostimulancia a nootropika | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 433.1 | N06BX01 | meklofenoxat | parent. | 0.5 | GM | 83,53 | H |
| 433.2 | NO6BX02 | pyritinol | parent. | 0.3 | GM | 57,25 | H |
| 433.3 | N06BX03 | piracetam | parent. | 6 | GM | 57,25 | H |
| 11337 | GERATAM 3G | inj 4x15ml/3gm | UCB | B | |||
| 433.4 | N06BX18 | vinpocetin | parent. | 15 | MG | 24,98 | H |
| 434 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 434.1 | N07AA01 | neostigmin | p.o. | 60 | MG | 19,75 | |
| 53946 | SYNTOSTIGMIN | tbl 20x15mg(blistr) | SLO | SK | |||
| 434.2 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180 | MG | 25,86 | |
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 16,81 | |
| 434.4 | N07AA03 | distigmin | p.o. | 5 | MG | 5,82 | |
| 02360 | UBRETID | tbl 20x5mg | HNP | A | |||
| 02130 | UBRETID | tbl 50x5mg | HNP | A | |||
| 434.5 | N07AA30 | ambenonium | p.o. | 60 | MG | 18,04 | |
| 435 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 435.1 | N07AA01 | neostigmin | parent. | 2 | MG | 18,04 | |
| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK | |||
| 435.2 | N07AA02 | pyridostigmin | parent. | 10 | MG | 113,20 | |
| 435.3 | N07AA03 | distigmin | parent. | 0.25 | MG | 5,62 | |
| 436 | N07CA | léčiva proti vertigu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 436.1 | N07CA52 | cinarizin, kombinace (s dimenhydrinátem) | p.o. | 3 | DF | 4,79 | |
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 8,76 | |
| 436.3 | N07CA02 | cinarizin (do 25 mg včetně v jedné tabletě) | p.o. | 90 | MG | 1,86 | |
| 436.4 | N07CA02 | cinarizin (nad 25 mg v jedné tabletě) | p.o. | 90 | MG | 1,56 | |
| 436.5 | N07CA03 | flunarizin | p.o. | 10 | MG | 4,79 | |
| 437 | N07XX | ostatní léčiva nervové soustavy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 437.1 | N07XX01 | tirilazad | parent. | 150 | MG | 5226,44 | X |
| 438 | P01AB | chemoterapeutika ze skupiny nitroimidazolových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 438.1 | P01AB01 | metronidazol | p.o. | 2 | GM | 13,30 | |
| 438.2 | P01AB01 | metronidazol | p.rect. | 2 | GM | 8,36 | |
| 438.3 | P01AB02 | tinidazol | p.o. | 2 | GM | 13,30 | |
| 438.4 | P01AB03 | ornidazol | p.o. | 1.5 | GM | 22,00 | |
| 439 | P01BA | antimalarika ze skupiny aminochinolonových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu hydroxychlorochinem ordinuje infekcionista, revmatolog a dermatolog:
- a) systémový lupus erythematodes,
- b) revmatoidní arthritis,
- c) juvenilní chronická arthritis,
- d) diskoidní forma lupus erythematodes.
Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)